Logo image of TVTY

Tivity Health Inc (TVTY) Stock Fundamental Analysis

NASDAQ:TVTY - Nasdaq - US88870R1023 - Common Stock

32.5  +0.02 (+0.06%)

After market: 32.51 +0.01 (+0.03%)

Fundamental Rating

2

Overall TVTY gets a fundamental rating of 2 out of 10. We evaluated TVTY against 102 industry peers in the Health Care Providers & Services industry. TVTY has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, TVTY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TVTY had positive earnings in the past year.
TVTY Yearly Net Income VS EBIT VS OCF VS FCFTVTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA 14.51%
ROE 67.5%
ROIC 21.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TVTY Yearly ROA, ROE, ROICTVTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K

1.3 Margins

Industry RankSector Rank
OM 28.32%
PM (TTM) 17.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TVTY Yearly Profit, Operating, Gross MarginsTVTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), TVTY is creating value.
The number of shares outstanding for TVTY has been increased compared to 1 year ago.
TVTY has a better debt/assets ratio than last year.
TVTY Yearly Shares OutstandingTVTY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
TVTY Yearly Total Debt VS Total AssetsTVTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

TVTY has an Altman-Z score of 2.97. This is not the best score and indicates that TVTY is in the grey zone with still only limited risk for bankruptcy at the moment.
TVTY has a Debt/Equity ratio of 2.97. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Altman-Z 2.97
ROIC/WACC2.54
WACC8.45%
TVTY Yearly LT Debt VS Equity VS FCFTVTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.47 indicates that TVTY has no problem at all paying its short term obligations.
A Quick Ratio of 2.47 indicates that TVTY has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
TVTY Yearly Current Assets VS Current LiabilitesTVTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for TVTY have decreased strongly by -30.13% in the last year.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
TVTY shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.68%.
The Revenue has been decreasing by -0.80% on average over the past years.
EPS 1Y (TTM)-30.13%
EPS 3Y-11.9%
EPS 5Y7.59%
EPS Q2Q%0%
Revenue 1Y (TTM)29.68%
Revenue growth 3Y-7.41%
Revenue growth 5Y-0.8%
Sales Q2Q%17.96%

3.2 Future

TVTY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.95% yearly.
The Revenue is expected to grow by 12.89% on average over the next years. This is quite good.
EPS Next Y12.9%
EPS Next 2Y12.13%
EPS Next 3Y10.31%
EPS Next 5Y9.95%
Revenue Next Year14.69%
Revenue Next 2Y13.45%
Revenue Next 3Y12.7%
Revenue Next 5Y12.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TVTY Yearly Revenue VS EstimatesTVTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
TVTY Yearly EPS VS EstimatesTVTY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.31 indicates a rather expensive valuation of TVTY.
Compared to an average S&P500 Price/Earnings ratio of 26.29, TVTY is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.16, TVTY is valued correctly.
TVTY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.31
Fwd PE 16.16
TVTY Price Earnings VS Forward Price EarningsTVTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.26
TVTY Per share dataTVTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.57
PEG (5Y)2.68
EPS Next 2Y12.13%
EPS Next 3Y10.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TVTY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Tivity Health Inc

NASDAQ:TVTY (6/27/2022, 8:04:47 PM)

After market: 32.51 +0.01 (+0.03%)

32.5

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-05 2022-05-05/amc
Earnings (Next)08-03 2022-08-03/amc
Inst Owners0.27%
Inst Owner Change0%
Ins Owners3.13%
Ins Owner Change0%
Market Cap1.62B
Analysts50
Price Target30.77 (-5.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.31
Fwd PE 16.16
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 12.68
P/tB N/A
EV/EBITDA 12.26
EPS(TTM)1.6
EY4.92%
EPS(NY)2.01
Fwd EY6.19%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.03
BVpS2.56
TBVpSN/A
PEG (NY)1.57
PEG (5Y)2.68
Profitability
Industry RankSector Rank
ROA 14.51%
ROE 67.5%
ROCE N/A
ROIC 21.46%
ROICexc N/A
ROICexgc 72.11%
OM 28.32%
PM (TTM) 17.25%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 2.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 2.97
F-Score8
WACC8.45%
ROIC/WACC2.54
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.13%
EPS 3Y-11.9%
EPS 5Y7.59%
EPS Q2Q%0%
EPS Next Y12.9%
EPS Next 2Y12.13%
EPS Next 3Y10.31%
EPS Next 5Y9.95%
Revenue 1Y (TTM)29.68%
Revenue growth 3Y-7.41%
Revenue growth 5Y-0.8%
Sales Q2Q%17.96%
Revenue Next Year14.69%
Revenue Next 2Y13.45%
Revenue Next 3Y12.7%
Revenue Next 5Y12.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A